Michael D. Clayman
2018
In 2018, Michael D. Clayman earned a total compensation of $3.2M as President, CEO and Co-Founder at Flexion Therapeutics, a 200% increase compared to previous year.
Compensation breakdown
| Bonus | $252,000 |
|---|---|
| Option Awards | $1,687,681 |
| Salary | $600,000 |
| Stock Awards | $650,716 |
| Other | $31,234 |
| Total | $3,221,631 |
Clayman received $1.7M in option awards, accounting for 52% of the total pay in 2018.
Clayman also received $252K in bonus, $600K in salary, $650.7K in stock awards and $31.2K in other compensation.
Rankings
In 2018, Michael D. Clayman's compensation ranked 3,575th out of 14,244 executives tracked by ExecPay. In other words, Clayman earned more than 74.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,575 out of 14,244 | 75th |
Division Manufacturing | 1,316 out of 5,762 | 77th |
Major group Chemicals And Allied Products | 462 out of 2,125 | 78th |
Industry group Drugs | 381 out of 1,814 | 79th |
Industry Pharmaceutical Preparations | 293 out of 1,388 | 79th |
Source: SEC filing on April 26, 2019.
Clayman's colleagues
We found four more compensation records of executives who worked with Michael D. Clayman at Flexion Therapeutics in 2018.